With a market capitalization approaching the $1 trillion mark, Eli Lilly is engaged in a close competitive race with Novo Nordisk for dominance in the obesity treatment sector. Market researchers ...

LLY's explosive GLP-1 growth, deep obesity pipeline and strong estimate momentum give it the edge over MRK despite a richer ...

The new "triple agonist" weight loss medication called retatrutide can help people lose an average of 28.7 percent of ...

In November, the Trump administration resurrected a Most Favored Nation (MFN) reference pricing policy, which would tie drug ...

Discover the top 11 websites to buy GLP-1 weight loss medications online. Our expert-reviewed guide helps you find safe, ...

My Dad Was Gay — But Married To My Mom For 64 Years. As She Died, I Overheard Something I Can't Forget.

The influencer has been sharing her postpartum health journey, adding GLP-1 medication to her Weight Watchers program.

Even when Americans have health insurance, they can have a hard time affording the drugs they've been prescribed.

Eli Lilly’s next-generation obesity treatment may prove highly effective for patients who have high BMI or suffer from ...

US health technology assessor the Institute for Clinical and Economic Review (ICER) today released a Final Evidence Report ...

Investing.com -- WW International Inc (NASDAQ:WW) stock jumped 11.5% Tuesday after the company, formerly known as Weight Watchers, announced a new integrated program providing comprehensive support ...